论文部分内容阅读
目的探讨静脉用蔗糖铁治疗孕产妇缺铁性贫血的有效性和安全性。方法 60例缺铁性孕产妇随机分为观察组和对照组,各30例。观察组静脉滴注蔗糖铁注射液,对照组口服琥珀酸亚铁片,比较两组治疗效果。结果治疗后两组血红蛋白、血清铁蛋白均有明显升高,且观察组优于对照组(P<0.05)。观察组总有效率为96.7%,高于对照组的90.0%,但差异无统计学意义(P>0.05)。两组不良反应较少。结论采用蔗糖铁纠正孕产妇缺铁性贫血,血红蛋白、铁蛋白上升幅度大,不良反应发生率低,疗效优于口服铁剂,值得推广。
Objective To investigate the efficacy and safety of intravenous iron sucrose in the treatment of iron deficiency anemia in pregnant women. Methods 60 cases of iron deficiency pregnant women were randomly divided into observation group and control group, each 30 cases. The observation group received intravenous infusion of sucrose iron, the control group oral succinate tablets, the treatment effect was compared. Results After treatment, hemoglobin and serum ferritin in both groups were significantly increased, and the observation group was better than the control group (P <0.05). The total effective rate in the observation group was 96.7%, which was higher than that in the control group (90.0%), but the difference was not statistically significant (P> 0.05). Two groups of adverse reactions less. Conclusion Sucrose iron is used to correct the iron deficiency anemia in pregnant women. The hemoglobin and ferritin increase greatly and the incidence of adverse reactions is low. The curative effect is better than that of oral iron, which is worth to be popularized.